BACKGROUND AND PURPOSE: Relatively little is known about the natural evolution of physical activity-related participation restrictions associated with Parkinson's disease (PD). We examined this issue prospectively, using continuous monitoring technology to capture the free-living ambulatory activity of persons with PD engaging in life situations. We specifically sought (1) to explore natural, long-term changes in daily ambulatory activity and (2) to compare the responsiveness of ambulatory activity parameters to clinical measures of gait and disease severity. METHODS: Thirty-three persons with PD participated (Hoehn and Yahr range of 1-3). Participants wore a step activity monitor for up to 7 days at baseline and again at 1-year follow-up. Mean daily values were calculated for parameters indicative of amount, intensity, frequency, and duration of ambulatory activity. Clinical measures included the Unified Parkinson Disease Rating Scale, the 6-Minute Walk, and Maximal Gait Speed. Parametric tests for paired samples were used to investigate changes in ambulatory activity parameters and clinical measures. RESULTS: Participants had significant declines in the amount and intensity of daily ambulatory activity but not in its frequency and duration (P < 0.007). Declines occurred in the absence of changes in clinical measures of gait or disease severity. The greatest 1-year decline occurred in the number of daily minutes participants spent engaging in at least moderate-intensity ambulatory activity. CONCLUSION: Continuous monitoring of ambulatory activity beyond mere step counts may serve as a distinct and important means of quantifying declining ambulatory behavior associated with disease progression or improved ambulatory behavior resulting from rehabilitation and medical and/or surgical interventions in persons with PD.
BACKGROUND AND PURPOSE: Relatively little is known about the natural evolution of physical activity-related participation restrictions associated with Parkinson's disease (PD). We examined this issue prospectively, using continuous monitoring technology to capture the free-living ambulatory activity of persons with PD engaging in life situations. We specifically sought (1) to explore natural, long-term changes in daily ambulatory activity and (2) to compare the responsiveness of ambulatory activity parameters to clinical measures of gait and disease severity. METHODS: Thirty-three persons with PD participated (Hoehn and Yahr range of 1-3). Participants wore a step activity monitor for up to 7 days at baseline and again at 1-year follow-up. Mean daily values were calculated for parameters indicative of amount, intensity, frequency, and duration of ambulatory activity. Clinical measures included the Unified Parkinson Disease Rating Scale, the 6-Minute Walk, and Maximal Gait Speed. Parametric tests for paired samples were used to investigate changes in ambulatory activity parameters and clinical measures. RESULTS:Participants had significant declines in the amount and intensity of daily ambulatory activity but not in its frequency and duration (P < 0.007). Declines occurred in the absence of changes in clinical measures of gait or disease severity. The greatest 1-year decline occurred in the number of daily minutes participants spent engaging in at least moderate-intensity ambulatory activity. CONCLUSION: Continuous monitoring of ambulatory activity beyond mere step counts may serve as a distinct and important means of quantifying declining ambulatory behavior associated with disease progression or improved ambulatory behavior resulting from rehabilitation and medical and/or surgical interventions in persons with PD.
Authors: Richard F Macko; Elaina Haeuber; Marianne Shaughnessy; Kim L Coleman; David A Boone; Gerald V Smith; Kenneth H Silver Journal: Med Sci Sports Exerc Date: 2002-03 Impact factor: 5.411
Authors: Elaina Haeuber; Marianne Shaughnessy; Larry W Forrester; Kim L Coleman; Richard F Macko Journal: Arch Phys Med Rehabil Date: 2004-12 Impact factor: 3.966
Authors: Arash Salarian; Heike Russmann; François J G Vingerhoets; Catherine Dehollain; Yves Blanc; Pierre R Burkhard; Kamiar Aminian Journal: IEEE Trans Biomed Eng Date: 2004-08 Impact factor: 4.538
Authors: Miriam R Rafferty; Peter N Schmidt; Sheng T Luo; Kan Li; Connie Marras; Thomas L Davis; Mark Guttman; Fernando Cubillos; Tanya Simuni Journal: J Parkinsons Dis Date: 2017 Impact factor: 5.568
Authors: Vrutangkumar V Shah; James McNames; Martina Mancini; Patricia Carlson-Kuhta; Rebecca I Spain; John G Nutt; Mahmoud El-Gohary; Carolin Curtze; Fay B Horak Journal: J Neurol Date: 2020-01-11 Impact factor: 4.849
Authors: Martina Mancini; Mahmoud El-Gohary; Sean Pearson; James McNames; Heather Schlueter; John G Nutt; Laurie A King; Fay B Horak Journal: NeuroRehabilitation Date: 2015 Impact factor: 2.138
Authors: Terry Ellis; Nancy K Latham; Tamara R DeAngelis; Cathi A Thomas; Marie Saint-Hilaire; Timothy W Bickmore Journal: Am J Phys Med Rehabil Date: 2013-06 Impact factor: 2.159